Venus Remedies Ltd.

View in App
227.50 +2.80 ▲1.3%

09 June 2023, 04:01:00 PM
Volume: 8,890

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.venusremedies.com
Market Cap 304.10 Cr.
Enterprise Value(EV) 292.67 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 19.88 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 11.45 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 344.38 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.66 Calculated using Price: 227.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.34 Cr. 13,366,988 Shares
FaceValue 10
About Venus Remedies Ltd.
Venus Remedies incorporated in 1989, is a pharmaceutical manufacturing company. The company provides formulations in area of anti-biotics and oncological therapeutics.

Venus Remedies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Venus Remedies Ltd. Performance

View details >>
1 Day
+1.25%
1 Week
-5.29%
1 Month
+11.17%
3 Month
+39.44%
6 Month
+19.14%
1 Year
+4.24%
2 Year
-27.97%
5 Year
+325.63%
10 Year
-21.50%

Venus Remedies Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.38 1.12 0.38 -4.13 -8.18 -8.23 -3.05 17.40 9.85
Return on Capital Employed (%) 14.06 5.74 5.35 2.00 1.17 -0.67 0.90 12.37 7.89
Return on Assets (%) 8.29 0.62 0.20 -2.12 -4.05 -3.85 -1.45 10.30 7.18

Venus Remedies Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 462 457 438 389 362 333 323 400 440 460
Non Curr. Liab. 162 222 212 180 158 137 96 58 46 58
Curr. Liab. 211 163 193 197 230 264 225 97 93 83
Minority Int.
Equity & Liab. 834 841 843 765 751 733 644 556 579 601
Non Curr. Assets 562 608 566 506 491 467 350 322 301 278
Curr. Assets 272 233 277 259 260 265 294 234 278 323
Misc. Exp. not W/O
Total Assets 834 841 843 765 751 733 644 556 579 601

Venus Remedies Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 542 464 418 400 372 322 339 548 599 556
Other Income 0 1 2 4 2 6 5 20 8 10
Total Income 542 465 420 404 375 328 345 568 607 566
Total Expenditure -403 -375 -337 -349 -333 -289 -299 -494 -537 -495
PBIDT 139 90 83 55 42 39 46 73 70 71
Interest -29 -41 -38 -36 -36 -25 -13 -13 0 0
Depreciation -40 -46 -42 -40 -34 -34 -32 -35 -34 -32
Taxation -5 3 -2 5 -3 1 -2 13 4 -11
Exceptional Items -9 -9 23
PAT 64 5 2 -17 -31 -29 -10 62 41 27
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 64 5 2 -17 -31 -29 -10 62 41 27
Adjusted EPS 56 5 1 -14 -25 -23 -8 50 30 20

Venus Remedies Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 52 53 68 47 59 31 45 78 132 41
Cash Fr. Inv. -104 -95 -67 3 -18 -11 -11 -5 56 -17
Cash Fr. Finan. 55 40 -1 -46 -44 -39 -35 -73 -162 -9
Net Change 3 -2 -1 3 -4 -20 -1 0 26 15
Cash & Cash Eqvt 6 4 4 7 4 -20 3 2 29 43

Venus Remedies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 35.89 40.81 40.81 40.81 40.81 41.76 41.76 41.76 41.76
Public 64.11 59.19 59.19 59.19 59.19 58.24 58.24 58.24 58.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 18.74 15.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Venus Remedies Ltd. Announcements

View details >>
Wed, 07 Jun 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies Awarded Ukrainian GMP Approval for Its Carbapenem Oncology Parenteral Facilities.
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel.
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper publication of Financial Results for the quarter and year ended on 31st March 2023.

Venus Remedies Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
S Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 5 Years High Increase in 5 Years

Venus Remedies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Venus Remedies Ltd. FAQ's

What is Venus Remedies share price?
Can I buy Venus Remedies shares now?
What is the Market Cap of Venus Remedies?
What are the key metrics to analyse Venus Remedies?
What is the 52 Week High and Low of Venus Remedies?
What is the trend of Venus Remedies share price?